# Irbesartan and Hydrochlorothiazide

NDC: 33342-057
Generic name: Irbesartan and Hydrochlorothiazide
Labeler / Manufacturer: Macleods Pharmaceuticals Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20120927

FDA application: ANDA202414

## Active ingredients

- HYDROCHLOROTHIAZIDE: 12.5 mg/1
- IRBESARTAN: 150 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"33342-057"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=33342-057
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1898f438-4571-4aab-ae06-9bf1aabf0486